Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
José M. Vicencio(Breast Cancer Now), Tony Ng(King's College London)
Cited by 30
Related Papers
Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells
|Science Signaling|2020|74
Chemotherapeutic regulation of the ROS/MondoA-dependent TXNIP/GDF15 axis; and derivation of a new organoid metric as a predictive biomarker
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0